of glucose uptake and is frequently downregulated in human cancers. Our lab previously 23 discovered that Ras activation suppresses TXNIP transcription and translation. In this report, we 24 developed a system to study how Ras affects TXNIP translation in the absence of transcriptional 25 affects. We show that whereas Ras drives a global increase in protein translation, it suppresses 26 TXNIP protein synthesis by reducing the rate at which ribosomes transit the coding region of 27 TXNIP mRNA. To investigate the underlying mechanism(s), we randomized or optimized the 28 codons in the TXNIP message without altering the TXNIP primary amino acid sequence. 29 Translation from these mRNA variants is still repressed by Ras, intimating that mRNA secondary 30 structure, miRNAs, RNA binding proteins, or codon usage do not contribute to the blockade of 31 TXNIP synthesis. Rather, we show that the N-terminus of the growing TXNIP polypeptide is the 32 target for Ras-dependent translational repression. Our work demonstrates how Ras suppresses 33 TXNIP translation elongation in the face of a global upregulation of protein synthesis and provides 34 new insight into Ras-dependent metabolic reprogramming. 37 Activating mutations in the small Ras GTPases (K-Ras, H-Ras, N-Ras) are among the most common 38 alterations in human cancer. The oncogenic mutations render the Ras proteins constitutively 39 active, which drives uncontrolled proliferation through the activation of the downstream 40 signaling pathways, such as the MAPK and PI3K pathways (1, 2). Ras activation also rewires 41 metabolism to accommodate the increased anabolic demands of rapidly growing and dividing 42 cells. For example, Ras stimulates glucose uptake and aerobic glycolysis for ATP generation, 43 diverts glycolytic intermediates into biosynthetic pathways, and upregulates glutaminolysis to 44 fuel central carbon metabolism (3-5). The glycolytic switch conferred by Ras activation has been 45 classically ascribed to its activation of c-Myc and HIF-1α, which directly drive the expression of 46 glucose transporters and glycolytic enzymes (6-8). More recent transcriptional analysis showed 47 that oncogenic Ras activates the expression of genes involved in a spectrum of anabolic pathways, 48 including the hexosamine, ribose and pyrimidine biosynthetic pathways (9). Each of these 49 biosynthetic pathways is fueled by glucose-derived carbons. However, in the absence of glucose 50 availability, flux through these biosynthetic pathways is limited. Thus, nutrient use must be 51 coupled with nutrient availability to sustain the rapid growth and division of transformed cells. 52 Thioredoxin interacting protein (TXNIP) is a critical negative regulator of cellular glucose uptake. 53 It inhibits glucose uptake by removing glucose transporters from the cell surface (10, 11). 54 Consequently, TXNIP loss is sufficient to drive glucose uptake and aerobic glycolysis (12-15). 55 Further, TXNIP can also promote oxidation of non-glucose fuels (16, 17). Therefore, low TXNIP 56 levels support the use of glucose as a fuel, whereas high TXNIP levels support the use of non-57 glucose fuels. In addition to this function in fuel choice, TXNIP has a number of additional anti-58 proliferative activities. For example, it can drive apoptosis by activating Ask1 and it can drive cell 59 cycle arrest by stabilizing p27 kip1 (18, 19) . Given these assorted functions, it is not surprising that 60 TXNIP functions as a tumor suppressor and is downregulated in a variety of human cancers (20-61 22). 62 Our previous data suggest that acute Ras activation in immortalized human fibroblasts 84 suppresses TXNIP transcription and translation (27) . Consistent with Ras blocking TXNIP 85 transcription, we observed a negative correlation between an H-Ras gene signature and TXNIP 86 expression in breast cancer, lung adenocarcinoma and pancreatic adenocarcinoma patient 87 samples using publicly available datasets (Fig.1A) . Experimentally, expression of activated H-Ras 88 (Ras G12V ) in murine embryonic fibroblasts (MEFs) completely abolished TXNIP mRNA and protein 89 expression ( Fig.1B and C) . The complete suppression of TXNIP transcription prevented us from 90 investigating whether Ras G12V regulates TXNIP post-transcriptionally. 91 To overcome this hurdle, we stably expressed the human TXNIP coding region in MondoA 92 knockout (MondoA KO) MEFs under the control of a constitutive promoter (i.e. control cells) and 93 examined effects of Ras activation by expressing Ras G12V (i.e. Ras G12V -expressing cells). All 94 subsequent experiments were conducted using these cells, unless otherwise specified. MondoA 95 KO MEFs lack endogenous TXNIP expression, enabling investigation of TXNIP expression from the 96 exogenous TXNIP allele (Fig.1D ). In this experimental system, the level of ectopic TXNIP mRNA 97 was higher in Ras G12V -expressing cells than in control cells ( Fig.1E ), yet TXNIP protein expression 98 was dramatically repressed by Ras G12V (Fig.1F ). This experiment suggests that Ras activation 99 induces TXNIP protein degradation or suppresses TXNIP synthesis. 100 101 Ras G12V inhibits TXNIP translation 102 We determined whether Ras G12V increases the rate of TXNIP protein degradation using two 103 methods. We first measured TXNIP protein degradation by blocking de novo protein synthesis 104 with cycloheximide (CHX). We observed that the half-life of TXNIP protein was about 1 h in 105 control cells and shorter (about 40 min) in Ras G12V -expressing cells, suggesting that Ras activation 106 can increase TXNIP turnover ( Fig.2A and B ). Consistent with this finding, the proteasome inhibitor 107 MG132 also increased TXNIP protein levels in Ras G12V -expressing cells, but the increase was not 108 to the levels observed in control cells (Fig.2C ). Collectively, these results suggest that Ras G12V 109 stimulates TXNIP degradation, but this increase in degradation rate does not fully account for the 110 difference in TXNIP levels in control and Ras G12V -expressing cells.
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A number of previous publications focused on TXNIP degradation (10, 29); therefore, we elected 112 to investigate whether Ras G12V affects the rate of TXNIP protein synthesis. Newly-synthesized 113 proteins were identified by labeling cells with a methionine analog (azidohomoalanine, AHA), 114 followed by their subsequent biotinylation using Click chemistry and enrichment on streptavidin 115 beads. To eliminate potential effects from degradation, cells were also treated with MG132. As 116 expected, Ras G12V -expressing cells had a lower level of steady-state TXNIP than control cells. 117 Furthermore, Ras G12V -expressing cells expressed significantly less newly-synthesized TXNIP 118 ( Fig.2D ). These data suggest that Ras G12V suppresses TXNIP protein synthesis. 119 We next designed a luciferase reporter assay to confirm whether Ras G12V suppresses TXNIP 120 expression by blocking its synthesis. In this assay, the TXNP CDS was fused upstream of and in 121 frame with the open reading frame encoding destabilized luciferase (dsLuc). To minimize 122 transcriptional effects, dsLuc expression was driven from a constitutive promoter. Thus, the 123 translation efficiency through the TXNIP CDS can be assessed by the luciferase activity ( Fig.2E ). 124 In the presence of CHX, the activity of TXNIP-dsLuc and dsLuc decreased with a similar half-life in 125 both control and Ras G12V -expressing cells, demonstrating that Ras G12V does not affect the 126 degradation of dsLuc or TXNIP-dsLuc ( Fig.2F ). By contrast, in the presence of MG132, the activity 127 of TXNIP-dsLuc was significantly lower in Ras G12V -expressing cells compared to control cells, 128 whereas Ras G12V did not block the increase in dsLuc activity (Fig.2G ). Together, these experiments 129 suggest that Ras G12V suppresses TXNIP expression primarily by decreasing TXNIP synthesis with 130 an increase in TXNIP degradation being a secondary contributing factor. Furthermore, the TXNIP 131 CDS is sufficient to confer the Ras G12V -dependent blockade of TXNIP synthesis. 132 133 Ras G12V inhibits translation elongation of TXNIP mRNA 134 Growth factor signaling promotes global protein synthesis (30, 31). Therefore, it is paradoxical 135 that Ras G12V suppresses TXNIP synthesis. To explore this contradiction further, we first 136 determined whether Ras G12V enhances global protein synthesis in MEFs using AHA labeling. As 137 expected, global protein synthesis was increased after Ras activation ( Fig.3A) . Thus, even though 138 Ras activation increases global translation, it appears to suppress translation of the TXNIP mRNA. 139 Since the TXNIP CDS is sufficient for translational repression by Ras G12V (Fig.2D and G), we 140 hypothesized that Ras G12V restricts TXNIP synthesis by blocking translation elongation of the 141 TXNIP message. To test this hypothesis, we used polysome profiling to determine how Ras G12V 142 affects the distribution of ribosomes on the TXNIP mRNA and other messages. To gauge 143 elongation rate, we used harringtonine, which is a translation initiation inhibitor that immobilizes 144 initiating ribosomes at the start codon without affecting elongating ribosomes. Thus, the rate at 145 which ribosomes are cleared from individual mRNAs in the presence of harringtonine can be used 146 to estimate the elongation rate (32, 33). Cell lysates from control and Ras G12V -expressing cells 147 were subject to velocity sedimentation in a sucrose gradient and the gradient was subsequently 148 fractionated. RNA was purified from each fraction and the levels of gene transcripts of interest 149 were determined by RT-qPCR. To simplify the analysis, qPCR values obtained for each fraction 150 were combined into "light" vs "heavy" bins and presented as a percentage of the total RNA (Light 151 fraction: mRNAs containing <=3 ribosomes; Heavy fraction: mRNAs containing >=4 ribosomes) 152 ( Fig.3B ). 153 We observed that Ras G12V -expressing cells had significantly more polysome-associated mRNA 154 present in the heavy fraction than control cells, confirming that Ras activation drives global 155 translation. Moreover, the majority of mRNA shifted from the heavy fraction to the light fraction 156 in the presence of harringtonine in both cell types, suggesting effective clearance of ribosomes 157 from the mRNA transcripts ( Fig.3B ). We first examined 5srRNA, which reflects global ribosome 158 association of mRNAs. Consistent with the chromatogram, 5srRNA was more enriched in the 159 heavy fraction from Ras G12V -expressing cells than from control cells. After harringtonine 160 treatment, 5srRNA shifted to the light fraction to the same extent for both cell populations 161 ( Fig.3C ). TXNIP mRNA was more enriched in the heavy fraction from Ras G12V -expressing cells than 162 from control cells. However, TXNIP mRNA was retained in the heavy fraction from Ras G12V -163 expressing cells after the harringtonine treatment, suggesting that active Ras slows the rate at 164 which ribosomes transit the TXNIP message ( Fig.3D ). For comparison, we examined Actin mRNA, 165 a housekeeping gene expected to be translated efficiently. Actin mRNA was more enriched in the 166 heavy fraction from Ras G12V -expressing cells and shifted to the light fraction for both cell types Translation elongation rate does not correlate with gene function 170 We wondered whether Ras's blockade of elongation is restricted to TXNIP or does it suppress 171 translation more broadly. To investigate this question, we analyzed data from a ribosome 172 profiling experiment designed to examine translation elongation in murine embryonic stem cells 173 (33). We generated the elongation profile for each gene transcript by calculating the change of Fig.4A ). An example of a "fast" gene is Hist1h2bc in C3, whereas an example of a "slow" gene is 180 Epha2 in C8 ( Fig.4B and C). Consistent with our polysome profiling data, ribosomes run off the 181 TXNIP message, in C7, relatively slowly whereas they run off the Actin message, in C5, relatively 182 quickly ( Fig.4D and E). We performed pathway analysis for the genes in C7 and found that this 183 cluster is not enriched for growth suppressors. Therefore, messages with elongation dynamics 184 similar to TXNIP do not generally encode growth suppressors. Further, this finding suggests that 185 Ras suppression of translation elongation might be restricted to TXNIP mRNA. 186 Even though growth suppressors did not cluster with TXNIP in C7, we wondered whether tumor 187 suppressors and oncogenes have different elongation dynamics, allowing differential 188 translational regulation by Ras or other oncogenic lesions. By comparing the ribosome retention 189 ratio of 134 oncogenes and 107 tumor suppressors, we observed that the two groups have similar 190 elongation dynamics ( Fig.4F ). Together, these results suggest that rapid elongation dynamics are 191 not generally associated with messages encoding oncogenes, nor are slow elongation dynamics 192 associated with messages encoding tumor suppressors. 193 194 TXNIP mRNA primary sequence is not required for Ras G12V -dependent translational repression 195 We next investigated whether the sequence of the TXNIP message contributed to the Ras G12V -196 dependent blockade of translation elongation. First, we tested the contribution of the primary 197 sequence of the TXNIP mRNA. We used gene synthesis to create a TXNIP mRNA with extensive 198 silent mutations across the entire CDS. Furthermore, this artificial message, TXNIP-MUT, is 199 comprised of codons with similar usage frequencies in the mouse genome to those of the TXNIP- 200 WT mRNA ( Fig.5A ). In total, we altered 422 of 1176 bases of the TXNIP CDS without changing the 201 TXNIP primary amino acid sequence. As expected, TXNIP-WT and TXNIP-MUT mRNA levels were 202 comparable in control cells and were increased upon Ras activation ( Fig.5B ). Nevertheless, TXNIP-203 MUT was still repressed by Ras G12V , although to a lesser extent than TXNIP-WT ( Fig.5C ). This 204 suggests that the translational repression of TXNIP by Ras G12V is unlikely to be mediated by a 205 feature(s) of the primary sequence of the TXNIP mRNA, such as mRNA secondary structure, 206 miRNAs or sequence-specific RNA binding proteins. 207 The WT TXNIP mRNA is comprised of a significant number of sub-optimal codons and even some 208 rare codons. Therefore, we speculated that WT TXNIP mRNA might be at a competitive 209 disadvantage for translation machinery in cells where Ras G12V drives global translation. We again 210 used gene synthesis to generate an artificial TXNIP mRNA. In this case, we retained the coding 211 capacity of the TXNIP mRNA, but replaced sub-optimal codons with codons that are used most 212 frequently in the mouse genome. In total, we altered 240 of 1176 bases (Fig.5A ). This mRNA, 213 TXNIP-OPT was transcribed similarly to TXNIP-WT ( Fig.5B ). Yet, the level of TXNIP protein 214 encoded by the TXNIP-OPT mRNA was much higher than that expressed from the TXNIP-WT 215 mRNA, confirming that high frequency codons can increase the translation efficiency. However, 216 TXNIP-OPT was still subject to translational suppression by Ras G12V (Fig.5C ). This finding suggests 217 that Ras activation does not suppress translation of the TXNIP mRNA simply because it contains 218 sub-optimal or even rare codons. Further, the high level of mutation in the TXNIP-OPT mRNA also 219 supports the model that the primary mRNA sequence is not targeted by Ras G12V . 220 221 Ras G12V inhibits TXNIP translation elongation independent of TXNIP's mRNA primary sequence 222 Next, we investigated whether the primary sequence of the TXNIP mRNA is involved in the 223 elongation repression by Ras G12V . To test this, we examined the elongation rate of TXNIP-WT, -224 MUT and -OPT messages with and without Ras activation using polysome profiling and the 225 ribosome run-off assay (Fig.6A ). In the absence of harringtonine, the loading of ribosomes onto 226 all three TXNIP messages was identical in control and Ras G12V -expressing cells. However, after 227 harringtonine treatment, each TXNIP message was more highly enriched in the heavy fraction in 228 Ras G12V -expressing than in control cells ( Fig.6B-D) . As a control, Actin exhibited equally efficient 229 run-off in control and Ras G12V -expressing cells (Fig.6E ). These results further support the model 230 that Ras G12V suppresses translation elongation of the TXNIP mRNA independent of its primary 231 sequence or codon usage. 
TXNIP N-terminal peptide sequence mediates the translational repression by Ras G12V
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Together, our results suggest that a feature of the TXNIP protein sequence is targeted by Ras. 235 Therefore, we investigated which region of the TXNIP protein is necessary or sufficient for the 236 translational repression by Ras G12V . To achieve this goal, we fused different regions of TXNIP to 237 dsLuc ( Fig.7A ). As above, Ras G12V did not affect the accumulation of dsLuc activity but completely 238 suppressed the accumulation of TXNIP-dsLuc activity after MG132 treatment ( Fig.7B and C). Our lab previously showed that acute growth factor signaling leads to a dramatic and rapid 251 suppression of TXNIP expression. In that study, the reduction in TXNIP protein preceded the 252 reduction in TXNIP mRNA, suggesting that growth factor signaling impacts TXNIP protein 253 synthesis and/or degradation (27) . In this study, we show that Ras activation suppresses TXNIP 254 mRNA and protein expression. By bypassing transcriptional regulation, we show that Ras actively 255 represses translation elongation of TXNIP mRNA. Translating ribosomes continue to transit the 256 TXNIP message ( Fig.3 and Fig.6 ), albeit at a slower rate in the presence of Ras activation; 257 therefore, we suggest that Ras G12V slows the rate of elongation rather than causing ribosome 258 stalling. Ras activation also stimulates TXINIP turnover, but this mechanism only accounts for elongation of the TXNIP message. We speculate that this multi-faceted downregulation of TXNIP 264 expression by activated Ras helps ensure that adequate glucose is available to support Ras-driven 265 anabolic biosynthetic pathways. 266 Growth factor signaling is known to promote global protein synthesis, through upregulation of 267 translation initiation and elongation (30, 31); therefore, it is striking that Ras activation blocks 268 translation elongation on the TXNIP message. Like growth factor signaling, we show that Ras G12V 269 upregulates global protein synthesis in MEFs (Fig.3A ). However, Ras activation blocks TXNIP 270 synthesis. Our analysis of published polysome profiling data suggests that messages with similar 271 elongation dynamics to TXNIP do not generally encode growth/tumor suppressors ( Fig.4 ). This 272 finding suggests that Ras G12V -mediated translational inhibition might be restricted to TXNIP or a 273 smaller set of messages. 274 We next investigated the mechanisms by which Ras G12V specifically downregulates the translation 275 of TXNIP mRNA. The artificial TXNIP mRNAs, TXNIP-MUT and TXNIP-OPT, are both significantly 276 different from TXNIP-WT in primary sequence. TXNIP-MUT is designed to alter the coding 277 sequence without changing the overall codon usage frequency. Ras activation suppresses TXNIP 278 expression when it is encoded by TXNIP-MUT. Therefore, we propose that Ras regulates TXNIP 279 synthesis by a mechanism independent of mRNA primary sequence. TXNIP-OPT is designed with 280 optimal codon usage, i.e. with increased usage of high frequency codons, which positively 281 impacts the elongation rate (34-37). TXNIP-OPT is still subject to Ras G12V -dependent translational 282 repression, suggesting that suboptimal codon usage in the TXNIP message is not responsible for 283 the translational repression by Ras G12V . Supporting our model that the primary sequence of the 284 TXNIP mRNA is not targeted by Ras G12V , the rate at which ribosomes elongate on TXNIP-MUT and 285 TXNIP-OPT is much slower in the presence of Ras G12V . Together, these experiments suggest that 286 Ras does not target the primary sequence of the TXNIP mRNA to repress TXNIP synthesis. 287 In contrast to the lack of involvement of the sequence of TXNIP mRNA, we discovered that the 288 N-terminus of the TXNIP protein is necessary and sufficient for translational repression by Ras G12V . 289 We note that the effect of deleting the N-terminus of TXNIP is only partial ( Fig.7D ), suggesting 290 that other regions of TXNIP also contribute to the Ras-dependent blockade of TXNIP synthesis. 291 Using TXNIP truncation variants TXNIP(1-87)MUT and TXNIP(1-87)OPT, we show that the peptide 292 sequence rather than the mRNA sequence coding the first 87 amino acids is required for 293 translational repression. These data suggest that activated Ras targets the N-terminus of TXNIP 294 as it exits the ribosome, resulting in a decreased rate of translation elongation (Fig.8 ). The 295 dependence on the N-terminus of TXNIP for Ras-dependent repression is consistent with our 296 contention that the blockade of translation elongation by Ras may be restricted to TXNIP or to a 297 small group of proteins that show homology to the TXNIP N-terminus. 298 Accumulating evidence suggests that the nascent peptide chain regulates translation elongation 299 by peptide sequence-specific interaction with the ribosome exit tunnel, which is accompanied by 300 stalled ribosomal complexes (38-45). We observed two prominent peaks along TXNIP CDS 301 corresponding to amino acids 66 and 81 of the TXNIP protein ( Fig.4D) , which is an indication of 302 high ribosome density and potentially slow ribosome translocation. We propose that the slow 303 elongation dynamics in this region of the TXNIP mRNA provides an opportunity for co-304 translational regulation by Ras G12V . We examined the ribosome distribution on ARRDC4 transcript, 305 which is a TXNIP paralog that is also a potent negative regulator of glucose uptake (46). 306 Interestingly, ARRDC4 transcript also shows high ribosome density at the position corresponding 307 to amino acid 85 of ARRDC4 protein (data not shown), suggesting that its translation may also be 308 regulated by Ras. 309 Ras G12V targets the N-terminus of TXNIP, but we do not yet understand how that impacts 310 translation elongation. Interaction between the nascent peptide chain and the ribosome exit 311 tunnel affects the elongation dynamics (38, 39). In addition, co-translational modification of the 312 protein being translated can regulate protein synthesis (47, 48). Given these findings, it is possible 313 that Ras G12V modifies the nascent peptide chain of TXNIP N-terminus, likely indirectly, to impede 314 the peptide release and the elongation dynamics ( Fig.8 ). Consistent with this idea, TXNIP harbors 315 a number of conserved sites for potential post-translational modification within its first 87 amino 316 acids. A second possibility comes from the observation that modifications of ribosomal proteins 317 and rRNAs regulate translation in a growth phase-dependent manner and in response to 318 environmental signals (49, 50). Therefore, it is also possible that Ras G12V targets the ribosome 319 itself, through affecting its interaction with the nascent peptide chain of TXNIP N-terminus, to 320 achieve specific blockade of TXNIP elongation (Fig.8) . Additional studies will be necessary to test 321 these models and others. Our preliminary studies suggest that canonical Ras effector pathways 322 do not block TXNIP translation (data not shown). Thus, Ras may drive metabolic reprogramming the light fraction (mRNAs containing <=3 ribosomes) and the heavy fraction (mRNAs 424 containing >=4 ribosomes) ( Fig.3B and Fig.6A) . The values for the light/heavy fraction were 425 presented as % total. Experiments were repeated twice and representative experiments are 426 shown. Values were reported as mean ± sd of three technical replicates. Statistical significance 427 was determined using one-way ANOVA. 428 For polysome profiling of cells expressing TXNIP-WT, MUT or OPT (Fig.6 Vector Ras 
FIG 2 Ras G12V inhibits TXNIP translation (A)
Western blotting was used to determine the levels of the indicated proteins in the listed cell lines following a treatment time course with 40 μg/ml cycloheximide (CHX). Short (SE) and long (LE) exposures allow better visualization of the TXNIP signal. c-Myc and Sin3A serve as controls for proteins that turnover rapidly or slowly. (B) TXNIP protein levels in (A) were quantified using densitometry. Signals from short exposure (SE) or long exposure (LE) were used for quantification for the control cells (Vector) or the Ras G12V -expressing cells (Ras), respectively. The half-life (t 1/2 ) of TXNIP protein in each cell line was determined and indicated in the plot. (C) Western blotting was used to determine the levels of the indicated proteins in the listed cell lines following a treatment time course with 20 μM MG132. (D) Newly-synthesized proteins were enriched by labeling cells with azidohomoalanine (AHA), followed by biotinylation using Click chemistry and affinity purification using streptavidin beads (SA). Western blotting was used to determine the levels of steady-state (Input) and newly-synthesized (SA) TXNIP and 
